|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 9/16 | |
| A61K 47/69 | |||
| A61P 41/00 | |||
| A61P 35/00 | |||
| A61K 31/337 | |||
| A61K 31/436 | |||
| A61K 31/7088 |
| (11) | Patento numeris | 1507559 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 03747660.3 |
| Europos patento paraiškos padavimo data | 2003-05-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2005-02-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-07-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2003/013892 |
| Data | 2003-05-02 |
| (87) | Numeris | WO 2003/092741 |
| Data | 2003-11-13 |
| (30) | Numeris | Data | Šalis |
| 138589 | 2002-05-03 | US | |
| 190419 | 2002-07-02 | US |
| (72) |
IVERSEN, Patrick L., US
KIPSHIDZE, Nicholas, US
|
| (73) |
Sarepta Therapeutics, Inc.,
215 First Street, Cambridge, MA 02142,
US
|
| (54) | DELIVERY OF MICROPARTICLE-CONJUGATED DRUGS FOR INHIBITION OF STENOSIS |
| DELIVERY OF MICROPARTICLE-CONJUGATED DRUGS FOR INHIBITION OF STENOSIS |